V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006355 | 200014792 | 1.8 | 99.9 | null | 2021-03-21 | 2021-04-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100696584 |
| 200006358 | 200014794 | 1.78 | null | null | 2019-12-04 | 2019-12-18 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101792855 |
| 200006360 | 200014795 | null | 76.9 | null | null | 2016-03-31 | null | null | N | CARBOPLATIN + DOCETAXEL | 101602508 |
| 200006362 | 200014796 | 1.66 | 103.8 | Palliative (P) | 2021-12-23 | 2022-03-11 | DABRAFENIB | 02 | null | DABRAFENIB | 100224201 |
| 200006363 | 200014797 | null | 75.5 | Palliative (P) | 2018-05-30 | 2018-05-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100693184 |
| 200006364 | 200014798 | 1.75 | 54 | 03 | 2019-09-13 | 2019-09-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101645486 |
| 200006365 | 200014799 | null | 71.4 | Palliative (P) | 2019-05-15 | 2019-05-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101184290 |
| 200006367 | 200014801 | null | 68 | Palliative (P) | 2016-12-21 | 2018-03-16 | null | N | null | IPILIMUMAB + NIVOLUMAB | 100021790 |
| 200006368 | 200014802 | 1.66 | 60.3 | null | 2019-08-02 | 2019-08-16 | DABRAFENIB | 02 | null | DABRAFENIB | 100103099 |
| 200006369 | 200014803 | 1.78 | 60.2 | null | 2019-10-28 | 2019-11-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100276210 |
| 200006371 | 200014805 | 1.72 | 87.1 | null | 2021-09-20 | 2021-09-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100829890 |
| 200006373 | 200014807 | 1.72 | 84.6 | Palliative (P) | 2020-12-01 | 2020-12-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100830368 |
| 200006374 | 200014808 | 1.7 | 82.3 | Palliative (P) | 2020-01-23 | 2020-01-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100176529 |
| 200006376 | 200014810 | null | null | null | null | 2017-09-01 | null | null | null | BINIMETINIB + ENCORAFENIB | 101081559 |
| 200006380 | 200014812 | 1.78 | 71 | Palliative (P) | 2017-10-07 | 2018-09-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101368212 |
| 200006383 | 200014814 | 1.63 | 67.2 | Palliative (P) | 2019-05-30 | 2019-06-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101840608 |
| 200006385 | 200014815 | 0 | 0 | Palliative (P) | 2019-08-08 | 2019-08-09 | Temozolomide 200mg/m2 | 02 | null | TRIAL UNSPECIFIED | 101751732 |
| 200006386 | 200014816 | null | 118 | 03 | null | 2019-02-24 | null | null | N | BINIMETINIB + ENCORAFENIB | 101473146 |
| 200006388 | 200014817 | null | null | Palliative (P) | 2020-07-16 | 2020-07-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100790630 |
| 200006389 | 200014818 | 1.91 | 79.5 | Palliative (P) | 2020-10-30 | 2021-03-07 | INTERIM Trial | 02 | null | IPILIMUMAB + NIVOLUMAB | 100496681 |
| 200006390 | 200014819 | 1.8 | 58.1 | null | 2018-01-20 | 2018-01-22 | Ipilimumab | 02 | null | IPILIMUMAB | 101339222 |
| 200006393 | 200014822 | 1.65 | 63.5 | Palliative (P) | 2017-02-25 | 2017-02-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101027391 |
| 200006395 | 200014823 | 1.8 | 99.5 | Palliative (P) | 2019-05-19 | 2019-05-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | TRIAL UNSPECIFIED | 100805505 |
| 200006396 | 200014824 | 1.72 | 69.1 | 03 | 2016-04-19 | 2016-04-25 | Ipilimumab | 02 | N | IPILIMUMAB | 100394459 |
| 200006398 | 200014826 | 1.84 | 72.9 | Palliative (P) | null | 2021-11-12 | null | null | N | CARBOPLATIN + DOCETAXEL | 101150148 |
| 200006402 | 200014828 | 1.83 | 83 | Palliative (P) | 2018-02-15 | 2018-02-15 | DABRAFENIB | 01 | null | TRIAL UNSPECIFIED | 100229565 |
| 200006403 | 200014829 | null | 63 | Adjuvant (A) | 2021-04-22 | 2021-04-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101211441 |
| 200006410 | 200014832 | 1.6 | 88.5 | Palliative (P) | 2018-05-26 | 2018-05-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101617973 |
| 200006411 | 200014833 | 1.77 | 74 | Palliative (P) | null | 2017-08-17 | Ipilimumab | null | null | IPILIMUMAB | 100914365 |
| 200006414 | 200014835 | null | 60.2 | Adjuvant (A) | 2017-11-29 | 2017-12-13 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101114260 |
| 200006418 | 200014838 | 1.6 | 83.9 | Palliative (P) | 2016-06-12 | 2016-07-06 | Binimetinib + Encorafenib | 02 | N | DABRAFENIB | 101194611 |
| 200006421 | 200014840 | 1.78 | 74.5 | Palliative (P) | 2018-08-13 | 2018-08-26 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101834781 |
| 200006426 | 200014842 | 1.6 | 73 | Palliative (P) | 2019-06-13 | 2019-07-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101400664 |
| 200006429 | 200014843 | 1.53 | 92.8 | Palliative (P) | 2020-06-01 | 2020-06-09 | null | 02 | N | TRIAL UNSPECIFIED | 101807101 |
| 200006432 | 200014846 | 1.65 | null | Palliative (P) | 2017-06-26 | 2017-07-22 | Ipilimumab | null | N | IPILIMUMAB | 100940869 |
| 200006433 | 200014847 | 1.85 | 70.5 | Palliative (P) | 2016-07-06 | 2016-07-27 | Ipilimumab | 02 | N | IPILIMUMAB | 100478334 |
| 200006434 | 200014848 | 1.63 | 106 | null | 2015-08-09 | 2016-10-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101778917 |
| 200006435 | 200014849 | 1.7 | 57.6 | Palliative (P) | 2021-11-02 | 2021-11-21 | DABRAFENIB | 02 | N | DABRAFENIB | 101416584 |
| 200006436 | 200014850 | 1.76 | 92.6 | Neo-adjuvant (N) | 2019-07-26 | 2019-08-10 | null | N | null | IPILIMUMAB + NIVOLUMAB | 100760336 |
| 200006439 | 200014852 | 1.66 | 101 | Palliative (P) | null | 2019-05-22 | null | null | null | BINIMETINIB + ENCORAFENIB | 100927152 |
| 200006443 | 200014853 | 1.74 | 77 | 03 | 2019-11-04 | 2021-04-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101777147 |
| 200006448 | 200014856 | 1.6 | 64.95 | Palliative (P) | 2016-11-15 | 2017-01-11 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101219397 |
| 200006449 | 200014857 | 1.85 | 90 | Palliative (P) | 2019-06-10 | 2019-06-12 | Binimetinib + Encorafenib | 02 | null | IPILIMUMAB + NIVOLUMAB | 100752666 |
| 200006450 | 200014858 | null | 71 | Palliative (P) | 2016-11-29 | 2016-11-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100159130 |
| 200006451 | 200014859 | 1.72 | 104 | Palliative (P) | 2019-08-25 | 2019-08-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100210055 |
| 200006452 | 200014860 | 1.83 | 60.3 | null | 2017-02-18 | 2017-03-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100620057 |
| 200006453 | 200014861 | 1.67 | 111 | Palliative (P) | 2018-03-23 | 2018-03-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100699383 |
| 200006456 | 200014862 | 1.53 | 76.4 | Palliative (P) | 2018-01-16 | 2018-01-22 | null | null | null | CARBOPLATIN + DOCETAXEL | 101531999 |
| 200006458 | 200014864 | 1.91 | 62.7 | Palliative (P) | null | 2021-04-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101374505 |
| 200006460 | 200014866 | 1.81 | 76 | Palliative (P) | 2016-07-01 | 2016-07-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101387696 |